TBCRC45: AVIATOR: A Phase II Study Of Trastuzumab, Vinorelbine, and Avelumab ± PF-05082566 (4-1BB/CD137 Agonist) in HER2+ MBC

Administered By

Duke Cancer Institute

Awarded By

Johns Hopkins University

Contributors

Westbrook, Kelly W Principal Investigator

Start/End

April 3, 2019 - October 1, 2023